Activation of central melanocortin pathways by fenfluramine.
about
Pharmacotherapies for obesity: past, current, and future therapiesAlterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gainSerotonin regulates C. elegans fat and feeding through independent molecular mechanismsPharmacological targeting of the serotonergic system for the treatment of obesityAnorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbensSerotonin as a New Therapeutic Target for Diabetes Mellitus and ObesityEmerging role of the brain in the homeostatic regulation of energy and glucose metabolismPeripheral Serotonin: a New Player in Systemic Energy HomeostasisContribution of Neuroinflammation to the Pathogenesis of Cancer CachexiaHow Does the Brain Implement Adaptive Decision Making to Eat?Brain regulation of energy balance and body weight.Central nervous control of energy and glucose balance: focus on the central melanocortin systemThe Role of PVH Circuits in Leptin Action and Energy BalanceReward-Induced Eating: Therapeutic Approaches to Addressing Food CravingsA serotonin and melanocortin circuit mediates D-fenfluramine anorexiaBrain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptorAnorectic actions of prolactin-releasing peptide are mediated by corticotropin-releasing hormone receptorsSerotonin 2C receptor activates a distinct population of arcuate pro-opiomelanocortin neurons via TRPC channelsMelanocortin neurons: Multiple routes to regulation of metabolism.Antiobesity pharmacotherapy: new drugs and emerging targetsA G-protein-coupled estrogen receptor is involved in hypothalamic control of energy homeostasis.Critical determinants of hypothalamic appetitive neuropeptide development and expression: species considerations.Identification of neuronal enhancers of the proopiomelanocortin gene by transgenic mouse analysis and phylogenetic footprintingThe tyrosine kinase receptor Tyro3 enhances lifespan and neuropeptide Y (Npy) neuron survival in the mouse anorexia (anx) mutation.Brain glucosamine boosts protective glucoprivic feedingMelanocortin-3 receptors and metabolic homeostasis.Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself.Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome.Effect of serotonergic anorectics on food intake and induction of Fos in brain of mice with disruption of melanocortin 3 and/or 4 receptors5-HT obesity medication efficacy via POMC activation is maintained during agingInvolvement of 5-HT receptors in the regulation of food intake in Siberian hamsters.Wired on sugar: the role of the CNS in the regulation of glucose homeostasis.Lorcaserin Administration Decreases Activation of Brain Centers in Response to Food Cues and These Emotion- and Salience-Related Changes Correlate With Weight Loss Effects: A 4-Week-Long Randomized, Placebo-Controlled, Double-Blind Clinical Trial.The anorexigenic effect of serotonin is mediated by the generation of NADPH oxidase-dependent ROSMilnacipran, a serotonin and norepinephrine reuptake inhibitor, induces appetite-suppressing effects without inducing hypothalamic stress responses in mice.The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues.Pancreatic cancer cachexia: a review of mechanisms and therapeutics.Deconstructing antiobesity compound action: requirement of serotonin 5-HT2B receptors for dexfenfluramine anorectic effects.Pathophysiology and treatment of inflammatory anorexia in chronic disease.The use of serotonergic drugs to treat obesity--is there any hope?
P2860
Q21296814-EADC83B4-EA8A-4297-9A20-D4283FEFAC8AQ21561008-96843724-03A0-499E-AE6D-E7530EB45C77Q24649629-517B9F32-74A4-4C4D-971D-AFA2A1619588Q24658013-15A57DA4-366E-45B1-98C2-A209F84F81F2Q24674037-3AF555B7-D72C-4903-AF5C-AFAC4E109A3EQ26749092-84D2C6CD-4ED3-4270-9A86-B209736BF3A1Q26766494-0D7A32A2-77EE-47EC-BC00-D5A884D27B54Q26775537-8FC0E974-FF21-444D-AA87-2AC1933083F7Q26778695-67D5892F-9674-48DD-AED3-9F5C156351F0Q26782933-21BEEACC-7667-43F2-9EE8-8FA083DCBA4BQ26865811-8C95BA7E-D274-4B46-89C3-87A064D1A2FBQ26994763-D296FFF3-9264-468A-B384-4C117F0C1A86Q28067395-76E2DC50-D8A3-4001-95BD-DBBB847314D2Q28074195-DE80E90B-5FC6-4AA4-8B72-3DACC1251AE1Q28506385-DF5724BD-F01A-4774-9867-C0FE2329564DQ28512879-EBCB9B9D-C915-42A1-A57B-559172EF6B31Q28570885-190FBCE0-407B-401D-921F-4F8AD7A9EF7DQ28585910-AD129627-2DB4-4DC2-BD4B-C45274527A8AQ30234481-7E851F6E-05BA-4625-B63D-91EABC888E4DQ30354242-5FD898D6-BB91-4DC6-84C2-DB843C43FB71Q30439688-3B492D6B-2E5E-4105-8BF4-28F52F5234DDQ33620916-DB01353D-4BE1-4148-A4B1-5A819E0394A0Q33724465-FF4D9FC8-835A-4E06-AD2C-84B076820D79Q33746241-5FA6B3D2-7827-4758-8622-399299F68DD8Q33772319-1EEEE155-6DB9-4927-A7CA-3E9C37B56A48Q33782186-E8BF0BDD-15D4-4BFA-B789-F5B2B4C8C702Q33991186-176DC449-7C28-421E-AA42-79DC1FD871F7Q34006076-4313D4B8-17EB-43D9-8831-05980C3CE989Q34009277-DB43A2EC-C063-4547-99F8-858FE8F89EECQ34185683-694F6B31-ED65-4560-831B-F8ABC45F70E4Q34415764-DEF28F70-2822-47C8-A39E-68E6DA0EA36CQ34508419-1E2E24DE-2CC2-411E-9F72-2E9DE0B0E3E5Q34533195-D3ACD8F3-9AFA-4F2E-9140-C3AE3B657B7EQ34551208-AC9C4796-59C2-4B66-9B67-195A684AB99BQ34600995-C4415162-629A-4BD4-A576-2411A523B653Q34655896-3322D34C-0EA0-4D7D-A88D-212DFF773793Q34660312-59A133E7-C7CB-40D4-813F-502A2ABAD325Q34661779-5ECC0505-CE2D-40D3-B152-F98CF2F73EB0Q34697279-E45F5B1D-53B0-4DAC-AB7A-82445C9E7D98Q34712327-47A03468-D714-4915-AD95-EB59D54A053E
P2860
Activation of central melanocortin pathways by fenfluramine.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Activation of central melanocortin pathways by fenfluramine.
@en
Activation of central melanocortin pathways by fenfluramine.
@nl
type
label
Activation of central melanocortin pathways by fenfluramine.
@en
Activation of central melanocortin pathways by fenfluramine.
@nl
prefLabel
Activation of central melanocortin pathways by fenfluramine.
@en
Activation of central melanocortin pathways by fenfluramine.
@nl
P2093
P50
P356
P1433
P1476
Activation of central melanocortin pathways by fenfluramine.
@en
P2093
Charlotte E Lee
Jacob N Marcus
James L Smart
Jeffrey B Tatro
Joel K Elmquist
Laurence H Tecott
Malcolm J Low
Marcelo Rubinstein
Roger D Cone
P304
P356
10.1126/SCIENCE.1072327
P407
P577
2002-07-01T00:00:00Z